Gordian Capital Singapore Pte Ltd Sells 1,170 Shares of McKesson Corporation $MCK

Gordian Capital Singapore Pte Ltd lowered its position in shares of McKesson Corporation (NYSE:MCK) by 85.4% during the third quarter, Holdings Channel.com reports. The firm owned 200 shares of the company’s stock after selling 1,170 shares during the quarter. Gordian Capital Singapore Pte Ltd’s holdings in McKesson were worth $155,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in the company. GGM Financials LLC bought a new position in McKesson during the 3rd quarter worth $25,000. State of Wyoming acquired a new stake in McKesson in the 2nd quarter worth about $29,000. Hopwood Financial Services Inc. bought a new stake in McKesson in the 3rd quarter valued at about $31,000. Abound Wealth Management grew its position in shares of McKesson by 104.3% during the 3rd quarter. Abound Wealth Management now owns 47 shares of the company’s stock worth $37,000 after purchasing an additional 24 shares in the last quarter. Finally, Delos Wealth Advisors LLC bought a new position in shares of McKesson during the second quarter worth approximately $35,000. 85.07% of the stock is currently owned by institutional investors.

Insider Transactions at McKesson

In other news, EVP Michele Lau sold 2,725 shares of the stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $990.00, for a total value of $2,697,750.00. Following the completion of the transaction, the executive vice president directly owned 3,247 shares in the company, valued at approximately $3,214,530. This represents a 45.63% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Thomas L. Rodgers sold 276 shares of the firm’s stock in a transaction on Monday, January 5th. The shares were sold at an average price of $816.18, for a total value of $225,265.68. Following the sale, the executive vice president directly owned 2,268 shares in the company, valued at approximately $1,851,096.24. This trade represents a 10.85% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 3,868 shares of company stock valued at $3,743,820. Corporate insiders own 0.08% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on the company. Robert W. Baird set a $968.00 price target on McKesson in a research report on Wednesday, January 14th. Weiss Ratings lowered McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a report on Thursday, February 5th. Wells Fargo & Company raised their price target on McKesson from $914.00 to $925.00 and gave the stock an “equal weight” rating in a research report on Thursday, February 5th. Barclays upped their price objective on shares of McKesson from $960.00 to $1,050.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 18th. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of McKesson in a research note on Wednesday, December 10th. Thirteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, McKesson presently has an average rating of “Moderate Buy” and an average target price of $960.93.

McKesson Stock Performance

McKesson stock opened at $928.60 on Wednesday. McKesson Corporation has a 52 week low of $635.00 and a 52 week high of $999.00. The stock has a market capitalization of $113.74 billion, a P/E ratio of 26.71, a price-to-earnings-growth ratio of 1.52 and a beta of 0.38. The stock has a fifty day moving average of $886.79 and a 200-day moving average of $820.88.

McKesson (NYSE:MCK) last released its earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.19 by $0.15. The firm had revenue of $106.16 billion for the quarter, compared to analysts’ expectations of $105.98 billion. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The business’s revenue for the quarter was up 11.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, research analysts forecast that McKesson Corporation will post 32.77 earnings per share for the current year.

McKesson Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be paid a $0.82 dividend. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $3.28 annualized dividend and a yield of 0.4%. McKesson’s dividend payout ratio is presently 9.43%.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.